Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin's Lymphoma

Abstract

The annual risk of transformation of FL is 3% continuing without plateau beyond 15 years. Advanced stage at diagnosis is predictive of future transformation. Clinically diagnosed transformation has an equal impact on outcome as biopsy proven transformation.